Abstract:Background G Protein Coupled Receptors and regulators of G-protein signalling (RGS), play a pivotal role in the signalling processes associated with atherosclerosis [1]. RGS5 is highly expressed in aortic tissue [2]. Development of atherosclerotic plaque is a complex process that involves foam cells originating from macrophages (Mφ) and/or vascular smooth muscle cells (VSMCs). Differentiation of Mφ and VSMC into various intermediary cells of varying inflammatory potency affects atherosclerotic plaque composition and vulnerability [3]. We hypothesize that RGS5 is involved in signalling of foam cell transition and thus, plaque biology. Purpose To evaluate the role of RGS5 on atherosclerotic plaque complexity and shifts of foam cell origin. Methods ApoE-/-RGS5+/+ and ApoE-/-RGS5-/- mice were fed a high fat Western Diet for 14 weeks. Cryosections bearing aortic valve cusps were used for staining. Lesion size was quantified on hematoxylin and eosin staining. Plaque composition was assessed by CD68, CD45, Oil red O and collagen staining. Triple staining was performed for CD45, CD68 and aSMA. Double immunofluorescent staining for CD45 and pro- and anti-inflammatory markers was carried out. Co-Localisation was analysed by Zeiss Zen. Data were analysed using Mann-Whitney-U test. Results Lesion size was significantly reduced in RGS5-deficient mice in comparison to control (in mm2: 0.398±0.02 vs 0.191±0.09, p=0.0001, n=15). Relative areas positive for Oil Red O and collagen did not differ between genotypes. Area positive for leukocyte marker CD45 increased significantly by 30.8% (p<0.0001, n=15), whereas area positive for CD68 was reduced by 10.3% (p=0.0292, n=15) in RGS5-deficient mice. Absence of RGS5 decreased co-localization of Mφ-derived foam cells by 23% (p=0.03734, n=4-5) while leading to an 5.8% increase in aSMA-derived foam cells compared to control. Area positive for pro-inflammatory M1 Mφ marker CD86 and iNOS increased by 36.3% and 36.8% after RGS5 knock-out (p<0.0001, n=15). No difference in M2 Mφ positive area was observed when RGS5 was lacking. Conclusion RGS5 promotes plaque formation. The number of Mφ-derived foam cells is increased by RGS5, while it reduces inflammatory M1 Mφ. Interestingly, there were no differences in numbers of M2 Mφ, indicating RGS5 inhibits VSMCs transition to M1 Mφ resulting in an overall decrease of CD68-positive foam cells. Further study is required to determine molecular signalling of RGS5 that modulates the phenotype of Mφ- and VSMC-derived cells. RGS5 could be useful as therapeutic target to suppress undesirable plaque phenotypes and to reduce acute cardiovascular events.

NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis Via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.

Abstract 19366: NG2 Ablation Aggravates Obesity and Hyperlipidemia but Reduces Atherogenesis

Ng2 Ablation Aggravates Obesity And Hyperlipidemia But Reduces Atherogenesis

Abstract 689: Loss of Smooth Muscle Cell Nogo-B Protects from Atherosclerosis Plaque Development

Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

Downregulation of G3BP2 Reduces Atherosclerotic Lesions in ApoE Mice

Ablation Of Ng2 Proteoglycan Leads To Deficits In Brown Fat Function And To Adult Onset Obesity

Cyclin G2 Promotes the Formation of Smooth Muscle Cells Derived Foam Cells in Atherosclerosis Via PP2A/NF-κB/LOX-1 Pathway.

Chondroitin Sulfate N-acetylgalactosaminyltransferase-2 Impacts Foam Cell Formation and Atherosclerosis by Altering Macrophage Glycosaminoglycan Chain

Ag1296 Enhances Plaque Stability Via Inhibiting Inflammatory Responses and Decreasing Mmp-2 and Mmp-9 Expression in Apoe-/- Mice

RGS5 balances macrophage vs vascular smooth muscle cell origin of foam cells in apoE-deficient plaques

Treatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortality

1800-LB: Reprogramming of Macrophage Metabolism by Pyruvate Dehydrogenase Attenuates Atherosclerosis through Mitigation of iNOS-Induced Foam Cell Formation

Gsα Regulates Macrophage Foam Cell Formation During Atherosclerosis

Protein Tyrosine Phosphatase SHP2 in Macrophages Acts as an Antiatherosclerotic Regulator in Mice

Epha2 Knockdown Attenuates Atherosclerotic Lesion Development in Apoe(-/-) Mice

Smooth Muscle Cell Notch2 Is Not Required for Atherosclerotic Plaque Formation in ApoE Null Mice

Endogenous Activated Angiotensin-(1-7) Plays A Protective Effect Against Atherosclerotic Plaques Unstability in High Fat Diet Fed Apoe Knockout Mice

IL-1β Inhibition Partially Negates the Beneficial Effects of Diet-Induced Atherosclerosis Regression in Mice

Selective Reduction in the Sphingomyelin Content of Atherogenic Lipoproteins Inhibits Their Retention in Murine Aortas and the Subsequent Development of Atherosclerosis.

Abstract 281: Nogo-B, a Novel Regulator of Macrophage Foam Cell Formation